VanEck Pharmaceutical ETF
PPH
#1352
ETF rank
NZ$1.63 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
NZ$187.64
Share price
-0.59%
Change (1 day)
27.94%
Change (1 year)

Expense ratio and fees for VanEck Pharmaceutical ETF (PPH)

Expense Ratio

Expense Ratio as of May 2025: 0.36%

Gross Expense Ratio

Gross Expense Ratio as of August 2026: 0.36%

Net Expense Ratio

Net Expense Ratio as of August 2026: 0.36%